Drug intelligence / Profile preview

SMOFlipid

Development stage
Approved
Lead developer
Fresenius Kabi
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

SMOFlipid is a sterile, intravenous lipid emulsion used as a source of calories and essential fatty acids for patients requiring parenteral nutrition who cannot eat or drink. It contains four types of fats—soybean oil, medium chain triglycerides (MCTs), olive oil, and fish oil—providing a well-balanced mixture of omega-3 and omega-6 fatty acids. The mechanism of action involves supplying biologically utilizable triglycerides that are hydrolyzed to free fatty acids by lipoprotein lipase; these serve as substrates for energy production via beta oxidation, support membrane structure and function, act as precursors for bioactive molecules (such as prostaglandins), and regulate gene expression. SMOFlipid is indicated in both adults and children (including preterm infants) on total parenteral nutrition (TPN). Clinical evidence suggests it may have additional benefits such as positive immunomodulatory effects, improved liver function due to low phytosterol content and high vitamin E levels, reduced hospital stays, fewer infections compared to other lipid emulsions, and better physiological similarity to human dietary fat intake[1][3][6][8].

Brand names
SMOFlipid
Other names
lipid injectable emulsion

Beyond the preview

Go deeper on SMOFlipid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SMOFlipid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call